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The T-box transcription factor Tbx5 can interact with Nkx2.5 and Gata4 transcription factors to synergistically regulate heart-specific genes in
the nucleus. While a nuclear role for Tbx5 is clearly defined, we have previously shown that Tbx5 shuttles from nuclear to cytoplasmic sites,
forming a complex with the PDZ-LIM protein LMP4 on the actin cytoskeleton. In this study, using a developmental series of chicken hearts, we
provide the first evidence for differential Tbx5 protein expression and sub-cellular localization during cardiogenesis. At the tissue level, we show
temporally and spatially restricted Tbx5 co-expression with LMP4. In cells co-expressing LMP4 and Tbx5 we demonstrate dynamic Tbx5 re-
localization from exclusively nuclear to nuclear and cytoplasmic expression in the atrio-ventricular cushion. Furthermore, in coronary vessel
development we show exclusive cytoplasmic localization of Tbx5, indicating a function for Tbx5 in the cytoplasm. In addition, we discover
unknown regulation of Tbx5 and LMP4 expression in epicardial tissue, suggesting a specific role for Tbx5 in epicardial formation. These studies
provide in vivo significance of the LMP4/Tbx5 protein interaction, suggesting both nuclear and cytoplasmic roles for Tbx5. The shuttling between
nuclear and cytoplasmic sites reveals a novel mechanism for Tbx transcription factor regulation in chicken heart development allowing new
insights for a better understanding of the molecular basis of hand/heart birth defects associated with TBX5 mutations.
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Mutations in the transcription factor TBX5 cause the
congenital disease Holt–Oram syndrome, which is characterized
by truncations of the upper limbs and heart malformations
(Basson et al., 1999; Li et al., 1997). The heart malformations
primarily include septal and conduction defects although valvular
abnormalities have also been reported (Basson et al., 1999; Mori
and Bruneau, 2004). While Tbx5 is critical for forelimb and heart
development in all vertebrates, little is known about its regulation
(Agarwal et al., 2003; Bruneau et al., 2001). In a protein–protein
interaction screen we identified a novel Tbx5 binding protein,
LMP4, a member of the PDZ-LIM protein family. When co-
expressed with Tbx5 in the cell, the transcription factor relocates
from the nucleus to cytoplasmic sites and binds LMP4 along the⁎ Corresponding author. Fax: +1 773 755 6385.
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doi:10.1016/j.ydbio.2006.09.023actin cytoskeleton (Krause et al., 2004). This sequestration of the
transcription factor at actin filaments has a negative regulatory
effect on Tbx5 target genes (Camarata et al., 2006).
Initial insights into Tbx5 cardiac function during develop-
ment have come from its mRNA expression profile. In chick,
zebrafish and mouse Tbx5 expression is initiated very early in
heart development and revealed expression throughout the
cardiac crescent and the early heart tube (Begemann and
Ingham, 2000; Bruneau et al., 1999; Liberatore et al., 2000). As
the heart tube develops, Tbx5 mRNA becomes restricted to the
more posterior regions that will later form the sinus venosus,
atria, and left ventricle of the four-chambered heart (Bruneau et
al., 1999; Liberatore et al., 2000). Whole mount mRNA in situ
hybridizations in the chicken revealed ubiquitous and dynamic
LMP4 expression in every heart chamber, as well as the outflow
tract (Krause et al., 2004). These studies have suggested
domains of Tbx5 and LMP4 co-expression as well as domains
where LMP4 is expressed in the absence of Tbx5.
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chicken have provided insight into the function of Tbx5 in heart
development. Despite expression early in development, knock-
out Tbx5del/del mice have demonstrated that Tbx5 is not essential
for heart tube formation or normal initiation of endocardial,
myocardial and epicardial layers (Bruneau et al., 2001).
However, Tbx5 is important for proper heart chamber patterning.
Heterozygous mutant Tbx5del/+ mice exhibit enlarged hearts
with abnormal chamber size, including a dilated right atrium and
ventricle as well as atrial septal defects (Bruneau et al., 2001). In
contrast, in both chicken and mouse, Tbx5 over-expression in
the myocardium results in a reduction of overall heart size and
reduced trabeculation of the ventricles (Hatcher et al., 2001;
Liberatore et al., 2000). Mis-expression of Tbx5 in the left or
right ventricle of the mouse and chicken revealed that the Tbx5
expression gradient between left and right ventricles is critical
for patterning of the ventricles and position of the inter-
ventricular septum (Takeuchi et al., 2003).
In order to interpret the phenotypes caused by Tbx5
manipulation, an appreciation of the step wise development of
the heart and its formation from multiple cell lineages is
essential. From the cardiac crescent, a linear tube forms,
consisting of myocardium, lined on the inside by endocardium.
The posterior portions of the tube will form the sinus venosus,
atria and left ventricle while the anterior portions will form the
right ventricle and outflow tract. During further development
the heart tube undergoes looping, followed by septation to form
the mature, four chambered heart. As looping occurs, a third
layer, the epicardium, is added, covering the outer surface of the
myocardium. The epicardium originates predominantly from
the proepicardial organ (PEO), an outgrowth of cells near the
septum transversum (Männer, 1992; Viragh and Challice,
1981). Following attachment of the PEO to the myocardium
along the inner curvature of the heart, the proepicardial cells
migrate to cover the surface of the myocardium. Recent work
has demonstrated that cells derived from the aortic sac also
contribute to the epicardium; however, these cells cover only the
distal portion of the outflow tract (Perez-Pomares et al., 2003).
The heart consists of myocardium, which forms cardiac
muscle, sandwiched between epicardial and endocardial layers
(Viragh et al., 1989). In addition to forming the endothelial
lining of the myocardium, endocardial cells undergo epithelial-
to-mesenchymal transition (EMT) to form the atrio-ventricular
and outflow tract cushions, which in turn contribute to the
formation of the heart valves and septum (De la Cruz et al., 1983;
Markwald et al., 1996). Epicardial cells have multiple functions
as well. In addition to covering the surface of the myocardium,
epicardial cells undergo EMT, giving rise to mesenchymal cells
which will migrate into the sub-epicardial space and myocar-
dium. Epicardially derived cells (EPDCs) will form cardiac
fibroblasts, the coronary arteries and even contribute to the atrio-
ventricular cushion and intraventricular septum (Dettman et al.,
1998; Gittenberger-de Groot et al., 1998; Perez-Pomares et al.,
2002; Vrancken Peeters et al., 1999).
As an inroad to understand Tbx5 function, many studies have
relied largely on Tbx5 mRNA distribution and mis-expression of
RNA levels during heart development. Our previous work inbiochemical and cell culture experiments demonstrated a regulatory
interaction between LMP4 and Tbx5 sub-cellular localization and
function (Camarata et al., 2006). To extend the in vitro findings and
to provide in vivo validation, this study examines LMP4 and Tbx5
protein co-expression and localization in different cell populations
in the developing chicken heart including coronary vessels.
Materials and methods
Tissue sectioning
Chicken embryos at specified developmental stages were dissected free of
membranes and placed into cold PBS. Samples were embedded in Tissue Tek
OCT (Sakura Finetek) and frozen in a dry ice/methanol bath. Sections were
sliced at 10–12 μm on a Leica CM3050S cryostat (Leica Microsystems) and
processed for immunohistochemistry as described.
Immunohistochemistry and imaging
Samples were fixed in 4% paraformaldehyde (PFA) followed by 1% Triton
X-100 permeabilization, blocking with 20% normal goat serum (NGS;
Invitrogen) and sequential incubation with primary and secondary antibodies
in PBS with 0.2% bovine serum albumin (BSA)+10% NGS. Affinity purified
rabbit polyclonal anti-LMP4 (Camarata et al., 2006) and anti-Tbx5 (Khan et al.,
2002) were used at a 1:500 dilution. In cases where tissue was double labeled for
Tbx5 and LMP4, LMP4 antibodies were directly coupled to rhodamine using
the EZ-Label protein labeling kit (Pierce Biotechnology). Anti-sarcomeric
myosin (MF20), developed by D.A. Fischman; anti-vimentin (AMF-17B),
developed by A.B. Fulton; and quail marker (QCPN), developed by B. Carlson
and J. Carlson, were obtained from the Developmental Studies Hybridoma Bank
(University of Iowa) and diluted at 1:500. Anti-caldesmon (CALD5; Sigma) was
diluted 1:1000. Primary antibodies were detected using Alexa 488- and Alexa
546-conjugated secondary antibodies at 1:1000 dilutions (Molecular Probes).
Filamentous actin was detected using Alexa Fluor 488 Phalloidin at 1:300
dilution (Molecular Probes). Nuclei were stained using DAPI (Roche) at 1:1000
dilution. To verify antibody specificity, the Tbx5 and LMP4 antibodies were
blocked by pre-incubation with 2 mg/ml of the respective peptides against which
they were raised, followed by immunohistochemistry as described (Fig. S1). In
addition, specificity of the secondary antibodies was confirmed by omitting the
Tbx5 or LMP4 antibodies in the reaction (Fig. S1Y-AA). Confocal microscopy
was performed using a Zeiss 510 META system (Zeiss, Inc) equipped with a
Plan Apochromat 63x/1.4 Oil DIC lens. Overview images were created using
the tiling feature, with a Plan Neofluar 25x/0.80 Imm DIC objective. Images
were processed in Adobe Photoshop CS2.
Generation of chimeras
Quail to chick chimeras were generated as follows. PEOs were
harvested from HH16 or HH17 Japanese quails (Cotournix, cotournix
japonicum) and immediately transferred into windowed and inked HH16 or
HH17 chick hosts. Grafted quail PEOs were positioned underneath the dorsal
side of the heart tube next to the chicken proepicardium and 50 μl of a 10×
mixture of penicillin, streptomycin and fungizone (Gibco) was pipetted over the
yolk sac. Windows were covered with parafilm and embryos allowed to mature
until HH29 at 38°C. Following incubation, chimeric embryos were processed
for tissue sectioning as described above.
Results
Tbx5 and LMP4 protein expression during chicken heart
development
Tbx5 and LMP4 have revealed a dynamic mRNA
expression profile throughout heart development (Bruneau et
232 B. Bimber et al. / Developmental Biology 302 (2007) 230–242al., 1999; Krause et al., 2004; Liberatore et al., 2000). To
appreciate the respective protein distribution at the tissue and
cellular levels, we employed immunohistochemistry on a
developmental series of chicken embryos. To ensure the
specificity of the Tbx5 and LMP4 antibodies in the chicken,
we have performed various controls including Western blot,
immunohistochemistry on both cultured cells and tissue
cryosections (Fig. S1 and Camarata et al., 2006; Khan et al.,
2002). Fig. 1 provides an overview of four developmental
stages, showing adjacent cryosections processed with anti-Fig. 1. Tbx5 and LMP4 global expression in the avian heart. Adjacent cryosections fr
for either Tbx5 or LMP4. An anti-sarcomeric myosin antibody (MF20, red) was use
sections from HH20 chick embryos were stained for MF20 and DAPI (A), Tbx5 (B) an
for MF20 and DAPI (D), Tbx5 (E) and LMP4 (F). Asterisk in panel D marks AV cush
and DAPI (G), Tbx5 (H) and LMP4 (I). Asterisk in panel G marks AV cushion. (J–L
Tbx5 (K) and LMP4 (L). Double asterisk in panel J marks presumptive mitral val
proepicardial organ. Scale bars: C=200 μm; F, I=300 μm; L=400 μm.sarcomeric myosin (MF20), which marks cardiac myocytes,
DAPI to counter-stain cell nuclei and antibodies specific for
Tbx5 or LMP4. The MF20/DAPI images provide an outline of
the developing heart and its respective chambers as well as
identify myocardial tissue (Figs. 1A, D, G, J). We found that
for Tbx5, the protein expression is in agreement with published
mRNA expression data. At Hamburger and Hamilton stage
(HH) 20 (Hamburger and Hamilton, 1951), the chicken heart
has completed looping, but septation has not occurred, thus the
heart consists of only a single atrium and single ventricle. Tbx5om each stage were processed for immunohistochemistry using antisera specific
d to outline myocardium, while DAPI (blue) outlines all nuclei. (A–D) Sagittal
d LMP4 (C). (D–F) Transverse sections from HH25 chick embryos were stained
ion. (G–I) Transverse sections from HH29 chick embryos were stained for MF20
) Transverse sections from HH33 embryos were stained for MF20 and DAPI (J),
ve. LA: left atria; RA: right atria; LV: left ventricle; RV: right ventricle; PEO:
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although we observed a gradient of Tbx5 expression with
higher expression levels in the outer curvature of the
ventricular myocardium. At this stage the proepicardial organ
(PEO) included Tbx5 positive cells, although most proepicar-
dial cells did not express Tbx5 (Fig. 1B). This expression will
be addressed in greater detail in Fig. 3. LMP4 was expressed
predominantly in the epicardium covering the surface of the
heart but also in the PEO (Fig. 1C). By HH25, Tbx5 expression
became restricted to the structures derived from the posterior
elements of the heart tube including the left ventricle and both
atria (Fig. 1E). However, low Tbx5 expression was observed in
the right ventricle. At this developmental stage, a few cells in
the atrio-ventricular (AV) cushion began to express Tbx5,
while we could not detect any expression in the outflow tract
(Fig. 1E and data not shown). Similar to HH20, LMP4 was
expressed predominantly in the superficial epicardium with
little expression within the myocardium (Fig. 1F). In addition,
LMP4 was expressed in both the AV cushion and outflow tract
(Fig. 1F and data not shown). At HH29, Tbx5 continued to be
expressed in the left ventricle and both atria (Fig. 1H).
However, at this later developmental stage Tbx5 was
distributed evenly throughout the AV cushion, adopting a
new expression domain. Similar to earlier stages, LMP4 was
expressed predominantly in the epicardium, although isolated
cells within the myocardium expressed LMP4 (Fig. 1I). The
latter will be addressed in greater detail in Fig. 4. LMP4
remained expressed in the AV cushion at this stage. By HH33,
Tbx5 revealed continued expression in the left ventricle and
both atria (Fig. 1K). While some Tbx5 expression remained in
the trabeculations, overall the expression in the right ventricle
was significantly reduced at this developmental stage. Tbx5
was also down-regulated in most of the AV cushion, although
some expression remained in the area of the presumptive mitral
valve (Figs. 1J–K, double asterisk). Expression in this region
will be addressed in more detail in Fig. 2. As in earlier stages,
LMP4 was expressed in the epicardium and AV cushion.
Expression in the myocardium was hardly detectable, except
for a small number of isolated LMP4 positive cells (Fig. 1L).
In conclusion, Tbx5 protein reveals dynamic distribution in
different cardiac structures during development. It is predom-
inantly expressed in myocardial tissue, initially more broadly
and later becomes restricted to the left ventricle and both atria.
In addition, Tbx5 protein is temporally expressed in the AV
cushion. LMP4 protein distribution is mostly limited to non-
myocardial tissues such as the epicardium and AV cushion.
Thus, co-expression of Tbx5 and LMP4 is apparently limited to
few domains including the AV cushion.
Tbx5 and LMP4 sub-cellular localization in the AV cushion
Tbx5 and LMP4 were co-expressed in the AV cushion in a
limited developmental time window. In the HH25 heart,
LMP4 was expressed in the AV cushion but Tbx5 was not,
with the exception of a few positive cells (Figs. 1E–F). Higher
magnification of the HH25 AV cushion confirmed the overall
absence of Tbx5 protein, and revealed that LMP4 waslocalized along filamentous structures in the cytoplasm
(Figs. 2A–D). In the HH29 heart, Tbx5 and LMP4 were
both uniformly expressed throughout the AV cushion (Figs.
1H–I). Higher magnification demonstrated that in the presence
of LMP4, Tbx5 localized to both the nucleus and cytoplasmic
sites (Fig. 2E). Like Tbx5, LMP4 was localized along
cytoplasmic filaments (Fig. 2F). The merged image revealed
significant co-localization of cytoplasmic Tbx5 with LMP4
(Fig. 2H). In vitro work has shown that the Tbx5/LMP4
complex localizes along actin filaments (Camarata et al., 2006;
Krause et al., 2004). Co-stain of an adjacent section for Tbx5
and the actin marker phalloidin revealed strong co-localization
between the cytoplasmic Tbx5 and actin, consistent with in
vitro findings (Figs. 2I–L).
By HH33, Tbx5 was down-regulated in much of the AV
cushion; however, limited Tbx5 expression remained in the
area of the presumptive mitral valve (Fig. 1K). High
magnification of this region is shown in Figs. 2M–O. The
myocyte marker MF20 stained the surrounding myocardium,
but not the presumptive valve or other AV cushion tissue (Fig.
2M). Tbx5 was expressed in endocardial cells lining the lumen
of the cushion (Fig. N, asterisk). Within the cushion tissue,
Tbx5 was localized exclusively to the nucleus, with no
cytoplasmic localization detectable (Fig. 2O). At this stage,
LMP4 remained expressed throughout the AV cushion (Figs.
1L and 2Q). Comparable to earlier stages, LMP4 was
localized to actin filaments (Fig. 2R, data not shown). While
we do observe LMP4-mediated re-localization of Tbx5 to the
actin cytoskeleton, co-expression is not sufficient for this
process to occur.
Tbx5 and LMP4 expression in epicardial formation
The epicardium is formed from the villous proepicardial
organ (PEO), an outgrowth of the septum transversum (Manner
et al., 2001). In the chick, the PEO is formed during HH14–16
and makes contact with the heart between HH17–18. Once the
PEO contacts the heart proper, proepicardial cells migrate onto
the myocardium and transition into epicardial cells. These cells
form a mesothelial sheet which will eventually envelope the sur-
face of the heart, completing aroundHH27 (Manner et al., 2001).
To examine Tbx5 and LMP4 expression and localization
during epicardial formation, we examined cryosections from
HH16–29 embryos. In Fig. 3, MF20 marks myocardial tissue,
but does not stain the PEO or epicardial tissue. In the HH16
embryo, when the PEO has not come into contact with the
myocardium, the PEO expressed LMP4, but not Tbx5 (Figs.
3A–D, asterisk). In contrast, the neighboring atrium and
ventricle expressed Tbx5 (Figs. 3A–B). However, by HH20,
a time point when the PEO has come into contact with the
myocardium, some cells of the PEO began to express Tbx5
(Figs. 3E–F, asterisk). Arrows mark the border between PEO
and myocardium. The areas of the PEO expressing Tbx5 were
those in closest proximity to the neighboring ventricle (Fig. 3F).
LMP4 remained expressed throughout the PEO (Figs. 3G–H,
asterisk). Both Tbx5 and LMP4 proteins were expressed in
the epicardium at this stage (Figs. 3I–L). Interestingly, despite
Fig. 2. Tbx5 and LMP4 sub-cellular localization in the atrio-ventricular cushion. Cyrosections were processed for immunohistochemistry using antisera specific for
Tbx5 or LMP4. MF20 marks myocardium, phallodin marks actin and DAPI outlines all nuclei. (A–D) The HH25 atrio-ventricular (AV) cushion is shown, stained for
Tbx5 (A), LMP4 (B) and DAPI (C). Merged image (D). (E–H) A region of the HH29 AV cushion is shown, stained for Tbx5 (E), LMP4 (F) and DAPI (G). Merged
image (H). (I–L) An adjacent cyrosection, showing a similar region of the AV cushion, is shown, stained for Tbx5 (I), actin marker phalloidin (J), DAPI (K) and merge
(L). (M–O) The HH33 presumptive mitral valve is shown. Merge between MF20 (red) and DAPI (blue) outlines myocardium and nuclei, respectively (M).
Presumptive valve is MF20 negative. Tbx5 was only expressed in limited areas of the valve (N). Asterisk indicates region of enlargement. Enlarged image of Tbx5
demonstrates nuclear only localization (O). (P–R) Images are from an adjacent section showing the presumptive mitral valve. Merge between MF20 and DAPI (P).
LMP4 was expressed throughout the presumptive valve (Q). Asterisk indicates region of enlargement. Enlarged image of LMP4 demonstrates filamentous cytoplasmic
localization (R). Scale bars: D, H, L, O, R=10 μm; N, Q=100 μm.
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Fig. 3. Expression and localization during epicardial formation. Cyrosections were processed for immunohistochemistry using antisera specific for Tbx5 or LMP4,
MF20 (red) to outline myocardium and DAPI (blue) to outline all nuclei. (A–D) Adjacent cryosections from HH16 embryos, showing the unattached PEO (asterisk)
and neighboring myocardium. (A–B) Section was stained for MF20 and DAPI (A) and Tbx5 (B). (C–D) An adjacent section was stained for MF20 and DAPI (C) and
LMP4 (D). (E–L) Cryosections from HH20 embryos are shown. (E–H) Adjacent cryosections show the PEO (asterisk) which has come into contact with the
myocardium. Arrows mark border between PEO and myocardium. (E–F) A section was stained for DAPI (E) and Tbx5 (F). An adjacent section was stained for DAPI
(G) and LMP4 (H). (I–L) Images show the epicardium covering the ventricle in the HH20 heart. Arrows mark border between epicardium and myocardium. A section
was stained MF20 and DAPI (I) and Tbx5 (J). An adjacent section was stained for MF20 and DAPI (K) and LMP4 (L). (M–P) Adjacent cryosections from HH25 show
the epicardium over the ventricle. Arrows mark border between epicardium and myocardium. A section was stained MF20 and DAPI (M) and Tbx5 (N). A similar
region from an adjacent section shows the epicardium over the ventricle, stained for MF20 and DAPI (O) and LMP4 (P). (Q–T) Adjacent cryosections show the HH25
AV groove. Arrows mark border between epicardium and myocardium. A section was stained for MF20 and DAPI (Q) and Tbx5 (R). An adjacent section was stained
for MF20 and DAPI (S) and LMP4 (T). (U–X) Adjacent cryosections from HH29 embryos show the epicardium over the ventricle. A section was stained for MF20
and DAPI (U) and Tbx5 (V). A similar region is shown, stained for MF20 and DAPI (W) and LMP4 (X). A: atria; V: ventricle. Scale bars: B, D=50 μm; F, H, J, L, N,
P, R, T, V, X=20 μm.
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within epicardial cells, while LMP4 was localized to
cytoplasmic sites, suggesting a lack of interaction between
the proteins at this stage of heart development. Co-staining of
an adjacent section for LMP4 and phalloidin revealed that
like in the AV cushion, LMP4 was localized to actin filaments
(data not shown and Camarata et al., 2006).By HH25, epicardial formation is nearly complete. Tbx5 was
no longer detected in the majority of epicardial cells (Figs. 3M–
N). However, cells expressing Tbx5 were occasionally observed
in the superficial epicardium, especially in the vicinity of the AV
groove (Figs. 3Q–R). As in HH20 hearts, LMP4 revealed a
cytoplasmic localization in epicardial cells (Figs. 3O–P). LMP4
was expressed in both the superficial epicardium and the
236 B. Bimber et al. / Developmental Biology 302 (2007) 230–242epicardially derived mesenchymal cells (EPDCs) of the sub-
epicardial space (Figs. 3S–T). Notably, we consistently
observed a decrease in the intensity of LMP4 expression
between cells of the superficial epicardium and sub-epicardial
space. This could be due to down-regulation of LMP4 during
EMT, but could also be caused by change in morphology due to
actin re-organization (Lu et al., 2001). By HH29, we could not
observe Tbx5 expression in any epicardial cells (Figs. 3U–V).
However, LMP4 continued to be expressed (Figs. 3W–X).
Thus, during epicardial development Tbx5 expression
becomes induced in proepicardial cells after they have
contacted the myocardium. The expression is exclusively
nuclear and persists until HH25, when Tbx5 protein remains
in a small number of cells in the superficial epicardium. LMP4
is expressed in the cytoplasm, localized along actin filaments,
throughout the proepicardium, epicardium and EPDCs of the
sub-epicardial space at all stages examined.
Tbx5 and LMP4 sub-cellular localization and cell-type specific
expression in myocardial tissue
During cardiac development, Tbx5 was initially expressed
broadly across the myocardium, and later became restricted to
the atria and left ventricle (Fig. 1). At all stages examined,
within the myocardium, higher power inspection demonstrated
that Tbx5 was localized exclusively in the nucleus of cells (Fig.
4A). Within the left ventricular and atrial myocardium, Tbx5
was, however, not expressed in all cells. Fig. 4 shows
representative regions from the HH29 left ventricle. Co-staining
for Tbx5 and MF20, a cardiac myocyte marker, revealed that
within the myocardium Tbx5 was expressed only in this cell
type (Figs. 4B–D). Moreover, co-staining of Tbx5 andFig. 4. Tbx5 and LMP4 expression and sub-cellular localization within the myocardiu
using antisera specific for myocyte marker MF20 and either Tbx5 or LMP4. (A) A
nuclear localization for the protein. (B–D) A lower magnification of the left ventricl
with DAPI (D). Arrows mark example MF20 negative regions. (E) A region of the le
region is shown, stained for LMP4 (F) and MF20 (G). Merged image (H). Overlay w
20 μm.vimentin, a fibroblast marker, indicated that Tbx5 was not
expressed in vimentin positive fibroblasts and supported our
findings with MF20 (Fig. S2). In contrast to Tbx5, the
myocardium was predominantly negative for LMP4 except
for a few isolated LMP4 expressing cells scattered throughout
the interstitium (Fig. 4E). Higher magnification demonstrated
that these cells did not express MF20, suggesting that they were
a distinct population from the Tbx5 expressing cells (Figs. 4F–
I). Of note, LMP4 was only expressed in a fraction of the total
MF20 negative cells. Only a small number of the LMP4 positive
cells co-expressed vimentin and the majority of vimentin
positive cells did not express LMP4 (data not shown).
Characterization of LMP4 positive cells within the
myocardium
Since LMP4 was expressed in both epicardial cells and
EPDCs of the sub-epicardial space, we wondered whether the
LMP4 positive cells within the myocardium were epicardially
derived. In order to directly test this possibility, we generated
quail-chick chimeras, an established technique for tracing
epicardial cells (Dettman et al., 1998; Perez-Pomares et al.,
1998). Details on the generation of quail-chick chimeras are
provided in the supplemental material. Chimeric embryos were
incubated until HH29, sectioned, and processed for immuno-
histochemistry for either LMP4 and the quail-specific antigen
QCPN or Tbx5 and QCPN in order to determine distribution
and expression of the proteins in epicardially derived cells. To
assess LMP4 expression of epicardially derived cells in the
myocardium, we counted the number of QCPN single positive
and QCPN/LMP4 double positive cells in sections from six
separate chimeric embryos. Surprisingly, only a small fractionm. Cyrosections from HH29 embryos were processed for immunohistochemistry
region of the left ventricle is shown, stained for Tbx5, demonstrating exclusive
e is shown, stained for Tbx5 (B). Merge between Tbx5 and MF20 (C). Overlay
ft ventricle is shown, stained for LMP4. (F–I) Higher magnification of a similar
ith DAPI (I). LV: left ventricle; myo: myocardium; epi: epicardium. Scale bars:
237B. Bimber et al. / Developmental Biology 302 (2007) 230–242of the QCPN positive cells expressed LMP4 (29/421, Figs.
S4A–D). In contrast, in the same sections, we observed greater
than 400 LMP4 positive cells that did not express QCPN.
Similar cell counting experiments were performed on sections
stained for Tbx5 and QCPN. We did not detect Tbx5 expression
in any QCPN positive cells in the myocardium or epicardium
(0/213, Figs. S4E–H).
These results demonstrate that only a small number of
proepicardially derived cells in the myocardium expressed
LMP4 and that the majority of proepicardially derived cells
down-regulate LMP4 as they migrate into the myocardium.
Furthermore, a small but significant number of non-myocyte
cells exist in the myocardium that expressed LMP4 most of
which do not appear to be derived from the proepicardium.
Tbx5 expression and localization in outflow tract
Consistent with previous whole mount in situ studies, we
could not detect Tbx5 expression in the outflow tract before
HH29 (data not shown). However, beginning at HH29, a cross
section of the outflow tract revealed a ring of Tbx5 expressing
cells lining the lumen (Fig. 5A). Similar expression in cells
lining the lumen was observed as late as HH39 (data not
shown). LMP4 was expressed throughout the outflow tract at all
stages examined (Fig. 5C, and data not shown). Higher
magnification of the inner edge of the lumen revealed
filamentous cytoplasmic appearance of Tbx5, with no detect-
able nuclear localization (Figs. 5E–F). The merge between
Tbx5 and caldesmon demonstrated that the Tbx5 expressing
cells co-expressed this smooth muscle marker (Fig. 5G). An
adjacent section stained for LMP4 confirmed co-expression of
this protein with its typical cytoplasmic filamentous localization
(Figs. 5H–I).Fig. 5. Tbx5 and LMP4 expression in outflow tract. Cryosections from HH29 chicke
Tbx5, LMP4 or caldesmon. A cross section of the outflow tract (OT) was stained for T
DAPI (D). White boxes indicate regions of enlargement. Enlarged view of the OT sta
view of the OT stained for LMP4 (H). Merge with DAPI (I).Tbx5 and LMP4 expression and localization in coronary vessel
development
Similar to the outflow tract, Tbx5 exhibited dynamic
expression across coronary vessel formation. Presumptive
coronary vessels were identified using the smooth muscle
marker caldesmon. An example region from the HH29 left
ventricle is shown in Figs. 6A–H. Tbx5 was not detected in
any caldesmon positive cells within the myocardium (Figs.
6A–D). This is consistent with our observation that Tbx5
myocardial expression at this stage was limited to myocytes
(Fig. 4). Unlike Tbx5, LMP4 was expressed in all caldesmon
positive cells (Figs. 6E–H).
Beginning at HH36, Tbx5 expression was identified in sub-
epicardial coronary vessels, but not in those of the interstitium.
An example vessel located in the left AV groove is shown in Fig.
6I. While Tbx5 had an exclusively nuclear localization in the
neighboring left atrium in the coronary vessel Tbx5 displayed
different localization. A higher power image showing the merge
between Tbx5 and DAPI demonstrated an exclusive filamentous
cytoplasmic Tbx5 distribution, with no nuclear localization
(Figs. 6J–K). A counter stain of the same section with
caldesmon revealed that Tbx5was expressed in the mesenchyme
surrounding the coronary smoothmuscle, with little overlap with
the caldesmon positive cells (Figs. 6L–M). An adjacent section
co-stained for LMP4 and DAPI showed the expected filamen-
tous LMP4 localization in the cytoplasm (Figs. 6N–O). Counter
stain of the same section with caldesmon revealed that LMP4
was expressed both in the mesenchyme surrounding the smooth
muscle and in the smooth muscle itself (Figs. 6P–Q).
By HH39, Tbx5 was expressed in all coronary vessels,
including those located in the interstitium. Unlike the vessels of
the HH36 heart, at this later developmental stage the Tbx5n embryos were processed for immunohistochemistry using antisera specific for
bx5 (A) and DAPI (B). A similar section of the OTwas stained for LMP4 (C) and
ined for Tbx5 (E). Merge with DAPI (F). Merge with caldesmon (G). Enlarged
Fig. 6. Tbx5 is localized to the cytoplasm when expressed in coronary smooth muscle. Cryosections from chicken embryos were processed for immunohistochemistry
using antisera specific for Tbx5, LMP4 or caldesmon. (A–D) Cryosections from HH29 chick embryos were stained for Tbx5 (A) and smooth muscle marker
caldesmon (B). Merged image (C). Overlay with DAPI (D). (E–H) A similar section was stained for LMP4 (E) and caldesmon (F). Merged image (G). Overlay with
DAPI (H). (I) A region of the left atrio-ventricular groove from a HH36 heart is shown, containing a portion of the left atria and a coronary vessel (arrow). (J–M)
Enlarged view of the coronary vessel stained for Tbx5 (J). Overlay of Tbx5 with DAPI (K). Caldesmon (L). Merge between Tbx5 and caldesmon (M). (N–Q) An
adjacent section was stained for LMP4 (N). Overlay of LMP4 with DAPI (O). Caldesmon (P). Merge between LMP4 and caldesmon (Q). (R–Y) A coronary vessel
located within the myocardium of a HH39 heart is shown. (R–U) Tbx5 (R), overlay with DAPI (S), caldesmon (T) and merge between Tbx5 and caldesmon (U). (V–Y)
An adjacent section is shown, co-stained for Tbx5 (V) and LMP4 (W).Merged image (X). Overlay with DAPI (Y). epi=epicardium;myo=myocardium; LA=left atria;
LV=left ventricle; OT=outflow tract. Scale bars=20 μm.
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showed continued expression in coronary vessels, and co-
staining of sections for Tbx5 and LMP4 demonstrated co-
localization of Tbx5 with LMP4 in these mature blood
containing vessels (Figs. 6V–Y).
In conclusion, the co-expression of LMP4 and Tbx5 and
exclusive cytoplasmic localization of Tbx5 in smooth muscle of
both coronary vessels and outflow tract suggest a general, yet
unknown role for Tbx5 in smooth muscle differentiation.
Discussion
We have previously demonstrated in both transfected and
primary epicardial cells that in the presence of the PDZ-LIM
protein LMP4, Tbx5 shuttles dynamically between the nucleus
and cytoplasm and, in a complex with LMP4, localizes to actin
filaments (Camarata et al., 2006; Krause et al., 2004). Thechange in Tbx5 sub-cellular localization represses the tran-
scription factor's ability to activate target gene promoters,
introducing a previously unknown mechanism for Tbx5
transcription factor regulation (Camarata et al., 2006).
Here we show experimental evidence for dynamic Tbx5
protein expression as well as differential nuclear and cytoplas-
mic localization of native Tbx5 during heart development, which
provides in vivo significance for the Tbx5/LMP4 regulatory
model. While the in vivo studies confirm our previous work with
cultured cells, they also reveal that the regulation of Tbx5 is
considerably more complex than anticipated.
Tbx5 protein is localized to the nucleus in myocardial tissue
The heart is composed of multiple cell types and lineages, and
in the different tissue layers, we find differential expression of
Tbx5 protein. The myocardium forms cardiac myocytes which
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been observed in this tissue, which provoked extensive studies on
Tbx5 expression and function within the myocardium (Bruneau
et al., 2001; Liberatore et al., 2000; Takeuchi et al., 2003). We
demonstrate the protein distribution in myocardial tissue follows
the Tbx5 mRNA expression profile, which indicates overall
regulation on a transcriptional rather than translational level.
Tbx5 protein is initially expressed broadly across the atrial and
ventricular myocardium, and gradually becomes restricted to the
atria and left ventricle. Within myocardial tissue, we find Tbx5
expression is limited to myocytes and has a nuclear localization
in these cells. LMP4, however, is only expressed in a few isolated
non-myocyte cells within the myocardium which do not co-
express Tbx5. Thus, in the absence of LMP4 co-expression,
Tbx5 has a default nuclear localization, as would be expected for
a transcription factor. The possibility existed that the LMP4
positive cells within the myocardium were of epicardial origin;
however, lineage tracing studies suggest that themajority of these
are not proepicardially derived. Our data further show that while
LMP4 is expressed in all epicardial cells and EPDCs of the sub-
epicardial space, the majority of EPDCs down-regulate LMP4 as
they migrate into the myocardium.
Tbx5 becomes localized to the cytoplasm in non-myocardial
tissue
In contrast to the myocardium, endocardial and epicardial
tissues do express both Tbx5 and LMP4 proteins. In the atrio-
ventricular (AV) cushion, an endocardially derived structure
that gives rise to multiple structures, including the valves, Tbx5
and LMP4 are co-expressed. However, while LMP4 is
expressed in the AV cushion throughout heart development,
Tbx5 expression is dynamic with the highest protein level
detected at HH29. At this developmental stage, Tbx5 is
distributed to both the nucleus and the cytoplasm, where it
co-localizes with LMP4. Interestingly, at HH33 when Tbx5
expression is limited to regions of the presumptive mitral valve,
the protein is localized to the nucleus alone, while LMP4
remains cytoplasmic. Thus, co-expression of both proteins is
not sufficient for Tbx5 re-localization to the cytoplasm and
suggests that either Tbx5 nuclear export or binding to LMP4 is
responsive to temporal and/or spatial signals in vivo. This
regulated change of nuclear to actin-associated distribution of
Tbx5 is supported by our previous in vitro findings (Camarata
et al., 2006). We do not see conclusive evidence of LMP4
localization to the nucleus and therefore it seems likely that
Tbx5 is shuttled from the nucleus either by a yet unidentified
transport protein or by an intrinsic shuttling signal within Tbx5
itself. These possibilities can be experimentally tested, and
studies are under way to investigate which cellular mechanism
is responsible for altering Tbx5 sub-cellular localization.
Tbx5 is dynamically expressed during epicardium
formation
In addition to dynamic sub-cellular localization, we find
novel regulation of Tbx5 expression in the formation of theepicardium. The cells of the epicardium originate from the
proepicardial organ (PEO). While LMP4 is expressed in the
PEO, the PEO is initially Tbx5 negative. When the PEO comes
into contact with the myocardium, some cells within the PEO
begin to express Tbx5. Of note, the Tbx5 positive cells are those
in closest proximity to the myocardium, suggesting that either
direct contact or diffusible factors up-regulate Tbx5 expression
in proepicardial cells. While epicardial cells at an early
developmental stage co-express LMP4 and Tbx5, Tbx5 remains
localized in the nucleus, indicating that the interaction of Tbx5
with LMP4 is a regulated process, responsive to local cues.
Notably, this co-expression, but lack of interaction is consistent
with our observation in cultured epicardial cells that have not
undergone EMT (Camarata et al., 2006). LMP4 remains a
constant marker for the epicardium; however, Tbx5 expression
in the epicardium appears to be transitory and is lost at later
developmental stages, corresponding to the time at which
epicardial formation is completed (Manner et al., 2001).
This transient expression of Tbx5 suggests that the protein
may play a temporally limited role in epicardial formation. Two
likely roles for Tbx5 function can be considered: epicardial
migration and/or differentiation from proepicardium into
epicardium. A role in cell migration has been suggested by
Hatcher et al. (2004), who used Tbx5 anti-sense knock-down in
cultured proepicardial explants to inhibit cell migration.
Interestingly, using retroviral over-expression of Tbx5 in the
PEO of chick embryos, the same group reported reduced
migration of cells from the PEO onto the heart. While the data
seem contradictory, it is possible that while Tbx5 is required for
migration of proepicardial cells, premature expression of Tbx5
in the PEO may have similar negative effects, either by direct
impairment of migration or triggering premature transition into
epicardial cells.
Tbx5 is expressed in the cytoplasm of smooth muscle cells
We found novel Tbx5 expression and localization in smooth
muscle of both coronary vessels and the outflow tract. While the
outflow tract does not express Tbx5 at earlier stages, at HH29
and beyond, we observed a ring of Tbx5 expressing cells lining
the lumen, that co-express the smooth muscle marker
caldesmon. LMP4 is co-expressed with Tbx5 in these cells,
and of considerable interest, Tbx5 has an exclusively cyto-
plasmic localization along the actin cytoskeleton. Tbx5 is
expressed only in the interior of the outflow tract at these later
stages of development, which may account for the fact that this
expression has not been detected by whole mount in situ
hybridization in other studies.
Tbx5 has a similar cytoplasmic localization in smooth
muscle cells of sub-epicardial and interstitial coronary vessels.
While Tbx5 is not expressed early, at later developmental stages
the protein is co-expressed with LMP4 in the cells of coronary
vessels. Similar to the outflow tract, in these vessels Tbx5 is
localized exclusively to the cytoplasm, in a complex with
LMP4. Initially, Tbx5 is expressed only in sub-epicardial
vessels, particularly those in the AV groove and near the aorta.
Of interest, at this stage, the Tbx5 expressing cells did not
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expressing smooth muscle. Such cells surrounding coronary
vasculature smooth muscle have been hypothesized to be
perivascular fibroblasts, cells that have the potential to become
vascular smooth muscle or pericytes (Dettman et al., 1998). By
HH39, Tbx5 expression is detected in nearly all coronary
vessels, including those within the myocardium. At this later
developmental stage, the Tbx5 expressing cells are caldesmon
positive, suggesting that Tbx5 expression may be involved in
the differentiation of cells into smooth muscle. The difference in
timing of Tbx5 expression in sub-epicardial versus interstitial
vascular structures could reflect the overall progression of
maturation of these vessels or deposition of smooth muscle
around vessels. Given the unique Tbx5 localization we observe
in these smooth muscle cells, it would be interesting to test the
impact of factors involved in smooth muscle differentiation
such as FGFs and VEGF on Tbx5 expression and sub-cellular
localization (Mu et al., 2005).
Surprisingly, in the cells of both the outflow tract and
coronary vessels, Tbx5 could not be detected within the nucleus
at any stage. While binding of Tbx5 to LMP4 may serve as a
method of transcriptional regulation, as we have demonstrated
in cultured cells (Camarata et al., 2006), the complete absence
of nuclear Tbx5 protein in differentiating smooth muscle cells
of coronary arteries may indicate that Tbx5 has additional
functions in the cytoplasm. In this context it is noteworthy that
the Tbx5/LMP4 complex is localized to the actin cytoskeleton,
which is consistent with other PDZ-LIM protein family
members such as Enigma, CLP-36, and Cypher/ZASP that are
thought to have roles as regulators of cyto-architecture and cell
motility (Guy et al., 1999; Kadrmas and Beckerle, 2004;
Vallenius et al., 2000; Zhou et al., 1999). An attractive
possibility for the function of LMP4-bound Tbx5 would be a
direct role in regulating actin dynamics, particularly during
differentiation processes. Future experiments will address the
potential transcription independent functions of Tbx5 in the
cytoplasm; however, disrupting cytoplasmic Tbx5 without
interfering with nuclear Tbx5 will remain a challenge. One
approach may involve creation of modified forms of Tbx5,
which localize to either the nucleus or cytoplasm.
Nuclear versus cytoplasmic Tbx5 localization and its role in
Holt–Oram Syndrome
Our observations with the chicken developing heart and
primary epicardial cells (Camarata et al., 2006) reveal a
previously unknown developmentally regulated expression of
Tbx5, with protein localization to both the nucleus and the
cytoplasm. The new findings on dynamic sub-cellular localiza-
tion of Tbx5 would suggest a function for Tbx5 outside the
nucleus.
Cardiac and skeletal malformations known as Holt–Oram
syndrome (HOS) in humans are caused by mutations in TBX5.
The majority of TBX5 mutations critical for disease manifes-
tation are thought to result in early termination and haploinsuf-
ficiency (Basson et al., 1999; Brassington et al., 2003);
however, increased TBX5 dosage, such as chromosome 12q2duplication, has been reported to also lead to HOS (Hatcher et
al., 2001; Vaughan and Basson, 2000). These data would
suggest that both under- and over-expression could cause fairly
similar if not identical phenotypes, making a case that
appropriate TBX5 levels are critical. A role for Tbx5 as a
transcription factor in the nucleus has been discussed in HOS;
however, a potential cytoplasmic function for Tbx5 has not been
appreciated in disease manifestation. When impaired, this
function, in addition to the nuclear role, may contribute to HOS
phenotypes. Arguably, cytoplasmic Tbx5 localization is only
observed in a subset of heart tissues and it is not observed in the
myocardium, where the most pronounced TBX5 phenotypes
have been reported. Of the structures where Tbx5 is localized to
the cytoplasm, the AV cushion has an obvious connection to
disease manifestation. The AV cushion contributes to the
formation of the heart valves as well as the interventricular,
atrial and atrioventricular septa, all structures particularly
affected when Tbx5 level is altered both experimentally and
in HOS (Basson et al., 1999; Bruneau et al., 2001). It is possible
that in cells of the AV cushion the amount of Tbx5 in the
nuclear/cytoplasmic compartments must be precisely controlled
for proper function, and therefore these cells would be
particularly sensitive to any alteration of Tbx5 levels. It is not
clear what consequences alterations in overall Tbx5 levels
would have on the ratio between nuclear and cytoplasmic
compartments, but it may not impact them equally. In addition,
we have found cytoplasmic Tbx5 distribution in developing
coronary arteries and cells of the outflow tract lumen. Although
the coronary arteries in HOS have not been well studied, various
vascular defects have been recognized in HOS patients
including patent ductus arteriosus, persistent left superior vena
cava, anomalous pulmonary venous return and aortic coarcta-
tion (Hatcher and McDermott, 2006). Given that Tbx5 appears
to be exclusively cytoplasmic in the coronary vessels,
examination of these structures for defects in HOS patients
and Tbx5 compromised animal models may give clues as to the
potential cytoplasmic function of Tbx5.
The data presented here indicate a specific role for Tbx5 in
epicardial formation, which would have significant implications
for the analysis of HOS phenotypes. Cells derived from the
epicardium form coronary fibroblasts and contribute to the
septum, AV cushion and coronary vasculature and therefore
defects in epicardial formation would directly impact these
structures. However, potentially of even greater importance,
signaling from the epicardium has been demonstrated to be
essential as a modulator of myocardial development. Thus,
subtle defects in the epicardium can result in significant
phenotypes within the myocardium (Kang and Sucov, 2005;
Manner et al., 2001; Stuckmann et al., 2003). Chicken embryos
in which epicardial formation and/or function is impaired have
abnormal chamber size as well as trabeculation and septal
defects, myocardial phenotypes which are also observed when
Tbx5 cardiac level is experimentally altered (Bruneau et al.,
2001; Gittenberger-de Groot et al., 2000; Liberatore et al., 2000;
Merki et al., 2005). While the epicardium is reported to be
present in mutant Tbx5del/+ mice (Bruneau et al., 2001), it is
possible that subtle defects in epicardial formation or function
241B. Bimber et al. / Developmental Biology 302 (2007) 230–242have remained undetected. Considering our new findings, an
epicardial specific Tbx5 knock-out mouse would be of particular
interest and complement published mutant Tbx5 mouse models.
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